Cookies help us improve your ABPI online experience. If you accept their use, continue using our site. or, find out more about cookies.
Ukraine - UK Pharmaceutical Industry Response
We stand in solidarity with the people of Ukraine and condemn the invasion of their country. As an industry dedicated to saving lives, we stand for peace.
ABPI 2021 Code of Practice
The ABPI Code of Practice sets out the requirements the industry must comply with and supports companies’ commitment to self-regulation and to operate in a professional, ethical and transparent manner.
We represent our members, using their insight and experience to tell the story of how they change the lives of millions of people every day.
Online Workshop on SMC: How to prepare and submit to SMC | 13-14 June 2022
Making high quality, evidence-based submissions to SMC can mean the difference between successful or very limited access to NHS Scotland for medicines.
MMIP | 21 June 2022
The Medicines Manufacturing Industry Partnership (MMIP)'s annual conference will take place face to face this year at Redworth Hall Hotel, County Durham.
SAVE THE DATE! ABPI 2022 Annual Conference 30 June | Delivering the Life Sciences Vision: 1 Year on
The UK’s Life Sciences Vision sets out an exciting blueprint for the industry in the UK. One year on from the publication, the ABPI is bringing together leaders from across Government, NHS, industry and patient organisations to take stock on what we have already achieved together and our direction for the years ahead.
Clinical trials are important for patients, they are beneficial to the NHS and they are good for the UK economy.
Manufacturing and quality
The UK biopharmaceutical industry has a long and proud record of high quality, reliable manufacturing of medicinal products The UK medicines industry is one of our leading manufacturing sectors, with exports worth £24 billion and generating a trade surplus of £4.9 billion in 2012.
This is the science of developing new tools, standards and approaches to evaluate the efficacy, safety, quality and performance of medical products in order to assess benefit-risk and facilitate a sound and transparent regulatory decision-making.
Drug safety - pharmacovigilance
Drug safety (also known as pharmacovigilance), is the science of detection, assessment, understanding and prevention of side effects which allows us to understand more about the risks and benefits of a medicine.
ABPI Blister Pack Carbon Footprint Tool
The aim of the tool is to provide a quick approximation of the carbon impacts of pharmaceutical tablets in blister packs.